In focus · trending topic

NEOT

17 stories · following the connections

Neothetics Announces Adjournment of Special Stockholders Meeting to Solicit Additional Votes for Merger With Evofem

By Nasdaq OMXJan 5, 2018, 10:15 PM UTC

Neothetics, Inc. and Evofem Biosciences, Inc. Announce Merger Agreement to Create Women’s Health Company

By Nasdaq OMXOct 17, 2017, 12:02 PM UTC

Neothetics Provides Business Update and Reports Second Quarter 2017 Financial Results

By Nasdaq OMXAug 10, 2017, 12:00 PM UTC

Neothetics Announces Review of Strategic Alternatives

By Nasdaq OMXJul 10, 2017, 9:45 PM UTC

Neothetics Announces Top-Line Results for Phase 2 Proof-of-Concept Study of LIPO-202 for the Reduction of Submental Subcutaneous Fat

By Nasdaq OMXJun 26, 2017, 12:01 PM UTC

Neothetics Provides Business Update and Reports First Quarter 2017 Financial Results

By Nasdaq OMXMay 11, 2017, 12:00 PM UTC

Neothetics to Provide a Business Update and Release First Quarter 2017 Financial Results Thursday, May 11th, 2017

By Nasdaq OMXMay 4, 2017, 12:01 PM UTC

Neothetics Announces Issuance by USPTO of Eighth Patent Directed to LIPO-202 Lead Clinical Asset

By Nasdaq OMXApr 5, 2017, 12:00 PM UTC